---------- Forwarded message ----------
From: Yahoo! News Search Results for asbestos cancer <rssfwd@rssfwd.com>
Date: Mon, Jul 7, 2008 at 2:40 PM
Subject: Baron & Budd Attorney Denyse Clancy Speaks at International Mesothelioma Program's First Annual Harvard Medical School ... (PR Newswire via Yahoo! Finance)
To: mesothelioma77@gmail.com
Denyse Clancy, an attorney and shareholder with the Dallas-based law firm Baron & Budd, P.C., spoke at the International Mesothelioma Program's First Annual Harvard Medical School Course, entitled Surgery-Based Multimodality Therapy for Malignant Pleural Mesothelioma.
Mon, 07 Jul 2008 18:20:00 GMT
___
Source: http://us.rd.yahoo.com/dailynews/rss/search/asbestos+cancer/SIG=11peo6bst/*http%3A//biz.yahoo.com/prnews/080707/lam066.html?.v=101
--
Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc
From: Yahoo! News Search Results for asbestos cancer <rssfwd@rssfwd.com>
Date: Mon, Jul 7, 2008 at 2:40 PM
Subject: Baron & Budd Attorney Denyse Clancy Speaks at International Mesothelioma Program's First Annual Harvard Medical School ... (PR Newswire via Yahoo! Finance)
To: mesothelioma77@gmail.com
Denyse Clancy, an attorney and shareholder with the Dallas-based law firm Baron & Budd, P.C., spoke at the International Mesothelioma Program's First Annual Harvard Medical School Course, entitled Surgery-Based Multimodality Therapy for Malignant Pleural Mesothelioma.
Mon, 07 Jul 2008 18:20:00 GMT
___
Source: http://us.rd.yahoo.com/dailynews/rss/search/asbestos+cancer/SIG=11peo6bst/*http%3A//biz.yahoo.com/prnews/080707/lam066.html?.v=101
--
Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc